---
figid: PMC4002851__13_165_crosswhitef1
figlink: /pmc/articles/PMC4002851/figure/f1-13_165_crosswhite/
number: Figure 1
caption: 'Summary of molecular mechanisms involved in pulmonary remodeling. In pulmonary
  artery smooth muscle cells, inhibition of the potassium channels leads to cell depolarization
  and calcium entry, stimulating excess calcium release from the sarcoplasmic reticulum
  leading to calcium-calmodulin–regulated cell proliferation. When growth factors
  (PDGF, VEGF, TGF-β) and mitogens (ET-1) bind to their receptors, various signaling
  pathways are activated which increase cytosolic calcium levels and activate the
  MAPK signaling pathway–stimulating transcription factors (c-fos, c-jun, c-myc, and
  so on) and increase cell proliferation. Prostacyclin’s antagonistic effects act
  by increasing cAMP concentration, which simultaneously inhibits MAPK signaling and
  activates the PKA/MLCK growth-suppressive pathway. The vasodilator nitric oxide
  diffuses into the cell and stimulates cGMP production via guanylyl cyclase that
  results in MLCK dephosphorylation that inhibits cell growth and relaxes the SMC,
  leading to vasodilation. Finally, depolarization of the mitochondrial membrane by
  the mitoKATP channels (see mitoKATP above) delays apoptosis by inhibiting cytochrome
  c release and generates hydrogen peroxide (H2O2), stimulating transcription factors
  that drive cell proliferation. Cyto-C, cytochrome c; CaM: calcium-calmodulin complex;
  S.R, sarcoplasmic reticulum; RyR, ryanodine receptor; PKA, protein kinase A; AC,
  adenylyl cyclase; GC, guanylyl cyclase; N.O., nitric oxide. Lightning bolt indicates
  hyperpolarization.'
pmcid: PMC4002851
papertitle: Molecular Mechanisms of Pulmonary Arterial Remodeling.
reftext: Patrick Crosswhite, et al. Mol Med. 2014;20(1):191-201.
pmc_ranked_result_index: '160337'
pathway_score: 0.974394
filename: 13_165_crosswhitef1.jpg
figtitle: Summary of molecular mechanisms involved in pulmonary remodeling
year: '2014'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4002851__13_165_crosswhitef1.html
  '@type': Dataset
  description: 'Summary of molecular mechanisms involved in pulmonary remodeling.
    In pulmonary artery smooth muscle cells, inhibition of the potassium channels
    leads to cell depolarization and calcium entry, stimulating excess calcium release
    from the sarcoplasmic reticulum leading to calcium-calmodulin–regulated cell proliferation.
    When growth factors (PDGF, VEGF, TGF-β) and mitogens (ET-1) bind to their receptors,
    various signaling pathways are activated which increase cytosolic calcium levels
    and activate the MAPK signaling pathway–stimulating transcription factors (c-fos,
    c-jun, c-myc, and so on) and increase cell proliferation. Prostacyclin’s antagonistic
    effects act by increasing cAMP concentration, which simultaneously inhibits MAPK
    signaling and activates the PKA/MLCK growth-suppressive pathway. The vasodilator
    nitric oxide diffuses into the cell and stimulates cGMP production via guanylyl
    cyclase that results in MLCK dephosphorylation that inhibits cell growth and relaxes
    the SMC, leading to vasodilation. Finally, depolarization of the mitochondrial
    membrane by the mitoKATP channels (see mitoKATP above) delays apoptosis by inhibiting
    cytochrome c release and generates hydrogen peroxide (H2O2), stimulating transcription
    factors that drive cell proliferation. Cyto-C, cytochrome c; CaM: calcium-calmodulin
    complex; S.R, sarcoplasmic reticulum; RyR, ryanodine receptor; PKA, protein kinase
    A; AC, adenylyl cyclase; GC, guanylyl cyclase; N.O., nitric oxide. Lightning bolt
    indicates hyperpolarization.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADCY9
  - ADCY6
  - ADCY4
  - MAPK14
  - KRAS
  - MAPK3
  - PRKAR2B
  - PLCG1
  - MAPK1
  - ARAF
  - MAPK8
  - BRAF
  - PLCG2
  - ADCY2
  - RAF1
  - PRKAR2A
  - PRKAR1A
  - ADCY8
  - ADCY3
  - VEGFD
  - ADCY7
  - ADCY10
  - MAPK13
  - MAPK12
  - JUN
  - ADCY1
  - PRKACG
  - TGFB1
  - PRKAR1B
  - TGFB3
  - MAPK11
  - MAPK9
  - TGFB2
  - FOS
  - MAP2K1
  - ADCY5
  - MAPK10
  - NRAS
  - GC
  - RYR1
  - VEGFA
  - KRIT1
  - PRKACA
  - PGF
  - VEGFB
  - HRAS
  - VEGFC
  - EDN1
  - PRKACB
  - MAP2K2
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: C-jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: TGF-B,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: TGF-B,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: TGF-B,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: c-fos
  symbol: c-fos
  source: hgnc_alias_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: GC
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: RyR
  symbol: RYR
  source: hgnc_alias_symbol
  hgnc_symbol: RYR1
  entrez: '6261'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: CaM
  symbol: CAM
  source: hgnc_alias_symbol
  hgnc_symbol: KRIT1
  entrez: '889'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: ET-1
  symbol: ET1
  source: hgnc_alias_symbol
  hgnc_symbol: EDN1
  entrez: '1906'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
